Agenus Inc (AGEN)
10.86
+0.36
(+3.43%)
USD |
NASDAQ |
May 17, 16:00
10.86
0.00 (0.00%)
After-Hours: 20:00
Agenus Shares Outstanding: 21.00M for May 3, 2024
Shares Outstanding Chart
Historical Shares Outstanding Data
Date | Value |
---|---|
May 03, 2024 | 21.00M |
April 17, 2024 | 20.99M |
April 12, 2024 | 20.95M |
March 31, 2024 | 20.99M |
March 08, 2024 | 20.95M |
February 21, 2024 | 19.97M |
February 09, 2024 | 19.96M |
December 31, 2023 | 19.72M |
November 03, 2023 | 19.07M |
September 30, 2023 | 19.07M |
August 04, 2023 | 18.98M |
June 30, 2023 | 18.37M |
May 05, 2023 | 17.44M |
April 17, 2023 | 17.08M |
March 31, 2023 | 17.08M |
March 15, 2023 | 16.63M |
December 31, 2022 | 15.28M |
November 04, 2022 | 15.24M |
September 30, 2022 | 14.75M |
August 04, 2022 | 14.16M |
June 30, 2022 | 14.14M |
June 17, 2022 | 14.14M |
May 06, 2022 | 13.55M |
April 11, 2022 | 13.51M |
March 31, 2022 | 13.34M |
Date | Value |
---|---|
January 31, 2022 | 12.86M |
December 31, 2021 | 12.84M |
November 05, 2021 | 12.84M |
September 30, 2021 | 12.38M |
August 04, 2021 | 11.66M |
June 30, 2021 | 11.26M |
May 04, 2021 | 11.12M |
April 23, 2021 | 11.12M |
March 31, 2021 | 10.89M |
March 15, 2021 | 10.23M |
December 31, 2020 | 9.804M |
November 05, 2020 | 9.508M |
September 30, 2020 | 9.458M |
August 03, 2020 | 9.172M |
July 27, 2020 | 8.737M |
June 30, 2020 | 8.571M |
May 07, 2020 | 8.489M |
April 24, 2020 | 8.369M |
March 31, 2020 | 8.165M |
March 12, 2020 | 8.080M |
December 31, 2019 | 6.891M |
November 01, 2019 | 6.868M |
September 30, 2019 | 6.868M |
August 05, 2019 | 6.866M |
June 30, 2019 | 6.863M |
Shares Outstanding Definition
The volume of stock shares issued by the company and in the hands of the public. This number entails how much is being traded in the open market. A decreasing shares outstanding over time may be the result of company buybacks. Companies frequently make stock buybacks and retire those buybacks as treasury stock.
Shares Outstanding Range, Past 5 Years
6.863M
Minimum
Jun 30 2019
21.00M
Maximum
May 03 2024
13.53M
Average
13.10M
Median
Shares Outstanding Benchmarks
Ligand Pharmaceuticals Inc | 17.96M |
Protalix BioTherapeutics Inc | 73.32M |
InfuSystems Holdings Inc | 21.30M |
PAVmed Inc | 9.432M |
Allogene Therapeutics Inc | 208.78M |